Montalban X - Search Results

1

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

Kappos L, Radue EW, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung HP, Derfuss T, Naegelin Y, Sprenger T, Mueller-Lenke N, Griffiths S, von Rosenstiel P, Gottschalk R, Zhang Y, Dahlke F, Tomic D; TOFINGO study group. Kappos L, et al. Among authors: montalban x. Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29. Neurology. 2015. PMID: 26024899 Free PMC article.

2

Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.

Río J, Nos C, Marzo ME, Tintoré M, Montalban X. Río J, et al. Among authors: montalban x. Neurology. 1998 Jun;50(6):1910-2. doi: 10.1212/wnl.50.6.1910. Neurology. 1998. PMID: 9633761 Clinical Trial.

3

Primary and transitional progressive MS: a clinical and MRI cross-sectional study.

Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V, Dousset V, Filippi M, Montalban X, Polman CH, Rovira A, de Sa J, Thompson AJ. Stevenson VL, et al. Among authors: montalban x. Neurology. 1999 Mar 10;52(4):839-45. doi: 10.1212/wnl.52.4.839. Neurology. 1999. PMID: 10078736

4

Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.

Borràs C, Río J, Porcel J, Barrios M, Tintoré M, Montalban X. Borràs C, et al. Among authors: montalban x. Neurology. 1999 May 12;52(8):1636-9. doi: 10.1212/wnl.52.8.1636. Neurology. 1999. PMID: 10331691

5

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Hérissé-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Camp SJ, et al. Among authors: montalban x. Brain. 1999 Jul;122 ( Pt 7):1341-8. doi: 10.1093/brain/122.7.1341. Brain. 1999. PMID: 10388799

6

Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules.

Durán I, Martínez-Cáceres EM, Río J, Barberà N, Marzo ME, Montalban X. Durán I, et al. Among authors: montalban x. Brain. 1999 Dec;122 ( Pt 12):2297-307. doi: 10.1093/brain/122.12.2297. Brain. 1999. PMID: 10581223

7

Diagnostic criteria for primary progressive multiple sclerosis: a position paper.

Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI. Thompson AJ, et al. Among authors: montalban x. Ann Neurol. 2000 Jun;47(6):831-5. Ann Neurol. 2000. PMID: 10852554

8

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.

Río J, Nos C, Tintoré M, Borrás C, Galán I, Comabella M, Montalban X. Río J, et al. Among authors: montalban x. Ann Neurol. 2002 Oct;52(4):400-6. doi: 10.1002/ana.10290. Ann Neurol. 2002. PMID: 12325067 Clinical Trial.

9

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Tintoré M, Rovira A, Río J, Nos C, Grivé E, Sastre-Garriga J, Pericot I, Sánchez E, Comabella M, Montalban X. Tintoré M, et al. Among authors: montalban x. Neurology. 2003 Jan 14;60(1):27-30. doi: 10.1212/wnl.60.1.27. Neurology. 2003. PMID: 12525713

10

Can the Expanded Disability Status Scale be assessed by telephone?

Lechner-Scott J, Kappos L, Hofman M, Polman CH, Ronner H, Montalban X, Tintore M, Frontoni M, Buttinelli C, Amato MP, Bartolozzi ML, Versavel M, Dahlke F, Kapp JF, Gibberd R. Lechner-Scott J, et al. Among authors: montalban x. Mult Scler. 2003 Mar;9(2):154-9. doi: 10.1191/1352458503ms884oa. Mult Scler. 2003. PMID: 12708811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

786 results

Search Page